Author | Robert Giugliano, MD

Articles

Lipid-lowering Injectable Antibodies: The Next Big Thing?

November 28, 2012

PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.